PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference
PacBio (NASDAQ: PACB) announced management will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PacBio (NASDAQ: PACB) announced management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 10:30 AM PT (1:30 PM ET) in San Francisco.
A live webcast will be available on the company investor site and a replay will be posted for at least 30 days after the event.
Details
News Market Reaction – PACB
On Dec 31, the first trading day after this news, PACB closed 8.09% above the previous close.
Data tracked by StockTitan Argus for the Dec 31 session.
Key Figures
- Conference date
- January 12, 2026
- Presentation at 44th Annual J.P. Morgan Healthcare Conference
- Presentation time (PT)
- 10:30 AM PT
- Scheduled PacBio management presentation
- Presentation time (ET)
- 1:30 PM ET
- Scheduled PacBio management presentation
- Webcast replay period
- 30 days
- Replay available following the J.P. Morgan presentation
Historical Context
-
Announcement of participation in Piper Sandler healthcare conference with webcast access.
-
Plan to attend multiple investor conferences with fireside chats and webcasts.
-
Q3 2025 results with lower revenue but improved margins and narrowed losses.
-
Study showing HiFi sequencing detected all known pathogenic variants in complex regions.
-
First clinical-grade long-read sequencer approval in China via Berry Genomics.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT (1:30 PM ET) in San Francisco, California.
A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.